ScholarIQanswers from OpenAlex & ORCID
Linping Gu
ResearcherPublications, citations & collaboration network
Linping Gu is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Linping Gu have?
ScholarIQindexed works
Linping Gu has 15 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Linping Gu have?
ScholarIQcitation count
Linping Gu has 212 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Linping Gu?
ScholarIQh-index
Linping Gu has an h-index of 5 in OpenAlex.
What is the i10-index of Linping Gu?
ScholarIQi10-index
Linping Gu has an i10-index of 4 in OpenAlex.
What is the OpenAlex record for Linping Gu?
ScholarIQopenalex
The OpenAlex for Linping Gu is on the source record.
What are the most-cited papers on Linping Gu?
ScholarIQmost cited works
Homologous recombination deficiency (HRD) can predict the therapeutic outcomes of immuno-neoadjuvant therapy in NSCLC patients
Zhen Zhou, Zhengping Ding, Jie Yuan, Shengping Shen, Hong Jian, Qiang Tan, Yunhai Yang, Zhiwei Chen, Qingquan Luo, Xinghua Cheng, Yongfeng Yu, Xiaomin Niu, Liqiang Qian, Xiaoke Chen, Linping Gu, Ruijun Liu, Shenglin Ma, Jia Huang, Tianxiang Chen, Ziming Li, Wenxiang Ji, Liwei Song, Lan Shen, Long Jiang, Zicheng Yu, Chao Zhang, Zaixian Tai, Changxi Wang, Rongrong Chen, David P. Carbone, Xuefeng Xia, Shun Lu
Clinical analysis of 95 cases of pulmonary sarcomatoid carcinoma
Linping Gu, Yunhua Xu, Zhiwei Chen, Yan Pan, Shun Lü
Durable Clinical Response of Lung Adenocarcinoma Harboring EGFR 19Del/T790M/in trans-C797S to Combination Therapy of First- and Third-Generation EGFR Tyrosine Kinase Inhibitors
Zhen Zhou, Yi Zhao, Shengping Shen, Linping Gu, Xiaomin Niu, Yunhua Xu, Téngfēi Zhāng, Jianxing Xiang, Xinru Mao, Shun Lü
No significant association between the XRCC3 Thr241Met polymorphism and lung cancer risk: a meta-analysis
Yunhua Xu, Linping Gu, Yingjia Sun, Bai-jun Cheng, Shun Lu
An open, observational, three-arm clinical study of 2–3 cycles of treatment as neoadjuvant therapy in operable locally advanced non-small cell lung cancer: An interim analysis
Linping Gu, Xue Wang, Yile Sun, Yunhua Xu, Xiaomin Niu, Ruiying Zhao, Yaxian Yao, Hong Jian, Yuchen Han, Jinwang Wei, Zhiwei Chen, Shun Lu